NEW YORK (GenomeWeb News) – Tony Pawson, winner of the 2008 Kyoto Prize in Basic Sciences and a researcher at Mount Sinai Hospital, has died at the age of 60, according to the Toronto Star.
In 1990, Pawson, a cancer researcher, and his team reported that they uncovered the mechanism of how cells communicate through signal transduction, a finding that led to his Kyoto award.
He was a professor of molecular genetics at the University of Toronto, and a distinguished investigator and former director of research at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital.
He received his PhD from King's College London, he pursued postdoctoral work at the University of California, Berkeley, and early in his career he was an assistant professor at the University of British Columbia.
Nashville, Tenn.-based molecular diagnostics firm Insight Genetics this week announced that David Burg has joined the company as associate director of business development. Burg will lead sales and marketing for the company's Insight Molecular Labs. Prior to joining Insight, Burg was regional sales director for Response Genetics. He has also been a senior executive oncology account manager with GlaxoSmithKline.
Two current and one former Stanford University researchers have received the Warren Albert Foundation Prize for their contributions to human genetics, Stanford said this week.
The prize was awarded to Professor of Genetics and Biochemistry Ronald Davis and Professor Emeritus of Biochemistry David Hogness, both currently at Stanford, and David Botstein, who is now on the faculty of Princeton University.
The three winners will share the $250,000 award, and they will be honored at a symposium at Harvard Medical School in October.
Hologic said in a filing with the Securities and Exchange Commission that Glenn Muir has resigned from the firm's board of directors, although he will continue to serve as executive VP of finance and administration and CFO.
The Lymphoma Research Foundation has named three new members to serve on its scientific advisory board, including Sandeep Dave, Laura Pasqualucci, and Eduardo Sotomayor.
Dave is director of the Molecular Genetics and Genomics Program in the Duke Cancer Institute at Duke University. Also an assistant professor at Duke, Dave's research has focused on applying high-throughput technologies such as microarrays and massively parallel sequencing to identify new therapeutic targets and markers for diagnosis and prognosis in patients with leukemias and lymphomas.
Pasqualucci is an associate professor of clinical pathology and cell biology in Columbia University’s Department of Pathology and Institute for Cancer Genetics, and at the Herbert Irving Comprehensive Cancer Center in New York. Her research is centered on studies of the molecular genetics of lymphoma.
Sotomayor holds a chair in hematologic malignancies at the Moffitt Cancer Center and is a professor of oncologic sciences and pathology and cell biology at the University of South Florida College of Medicine.
The Strategic News Service's Nutritional Microanalysis Global Initiative has appointed Leroy Hood, president of the Institute for Systems Biology, to serve on its scientific advisory board.
The initiative aims to create a new field of medicine and a research platform for understanding human health and disease and how diseases are connected to the human genome.
MolecularMD has appointed Glenn Miller to be its chief technology officer and executive VP. He will work to develop and deliver diagnostic solutions to speed the development and commercialization of targeted cancer therapies.
Miller previously was VP and head of personalized healthcare and biomarker strategy for AstraZeneca, and he formerly worked in a variety of posts at Genzyme, including as VP and GM of Genzyme Analytical Services, which was acquired along with Genzyme Genetics by LabCorp in 2010.
Avacta has named Trevor Nicholls as a non-executive director.
Nicholls is currently the chief executive of CAB International, a nonprofit. He is also non-executive chairman of Activiomics. He previously was chief commercial officer and executive vice president of Affymetrix, and was a cofounder and CEO of Oxagen.
Catherine Royer has joined Rensselaer Polytechnic Institute as a chair of the school's biocomputation and bioinformatics department and as a professor in the biology department. She will begin her new roles there this month.
Royer, a molecular biophysicist is currently director of the Center for Structural Biochemistry in Montpellier, France, a position she has held since 2007. Before that, she was a visiting director of research at the center. Her research focuses on the physical mechanisms through which biological molecules work.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.